COPD exacerbation with hypercapnic respiratory failure
The case
A 72-year-old woman with severe COPD (FEV1 38% predicted) presents to the emergency department with 3 days of worsening dyspnoea, increased purulent sputum and right-sided chest pain. She uses tiotropium, salmeterol/fluticasone and home oxygen at 2 L/min. She is alert, using accessory muscles, with respiratory rate 28/min and oxygen saturation 88% on 6 L/min via Hudson mask. Arterial blood gas on 28% oxygen: pH 7.31, PaCO2 8.7 kPa, PaO2 7.1 kPa, bicarbonate 32 mmol/L. Chest X-ray shows hyperinflation with no new consolidation. After nebulised salbutamol and ipratropium, intravenous hydrocortisone 200 mg and ceftriaxone 1 g, her work of breathing worsens. What is the most appropriate immediate management?
Options
- ABilevel non-invasive ventilation (EPAP 5–8 cmH2O)
- BVenturi 40% oxygen then recheck blood gas
- CIntravenous magnesium sulfate over 20 minutes
- DHigh-flow nasal oxygen at 50 L/min
- ERapid sequence intubation and ventilation
Think it through before you read on. Which single option is best, and why are the other four wrong?
Show the answer and explanation
Answer
A. Bilevel non-invasive ventilation (EPAP 5–8 cmH2O)
Why this is the right answer
This woman has acute-on-chronic hypercapnic (type 2) respiratory failure. The high bicarbonate shows she retains CO2 chronically, but the pH of 7.31 shows she is now acidotic and decompensating. After standard drug treatment she is getting worse, not better.
The COPD-X Plan (Lung Foundation Australia and the Thoracic Society of Australia and New Zealand, 2024) recommends non-invasive ventilation for an exacerbation with respiratory acidosis (pH below 7.35 with raised PaCO2) that persists after initial medical treatment [VERIFY]. Bilevel ventilation gives inspiratory pressure support to unload tired respiratory muscles and expiratory pressure to keep airways open.
Non-invasive ventilation reduces the need for intubation, shortens hospital stay and lowers mortality in this setting. It should be started early, in a monitored area, with a plan for what to do if it fails.
Oxygen should be titrated to a saturation of 88–92%. Giving more oxygen without ventilatory support in a CO2 retainer will worsen hypercapnia and drowsiness.
Intubation is reserved for patients who cannot protect their airway, are haemodynamically unstable, or fail a trial of non-invasive ventilation. She is alert and has not yet had that trial.
Why the other options are wrong
- B
More oxygen without ventilatory support raises the PaCO2 further; a one-hour wait is too long in a deteriorating patient.
- C
Magnesium is asthma treatment; it has no established role in COPD exacerbation.
- D
High-flow nasal oxygen helps type 1 failure but cannot provide the ventilatory support needed for worsening hypercapnia.
- E
Intubation comes after failed non-invasive ventilation, not before it, in an alert patient.
High-yield takeaway
In a COPD exacerbation with pH under 7.35 and raised PaCO2 after initial treatment, start bilevel NIV and keep saturations at 88–92%.
Reference: COPD-X Plan: Australian and New Zealand Guidelines for the Management of COPD (2024)
Common questions
What oxygen saturation should I aim for in a COPD exacerbation?
88 to 92%. Higher targets in a CO2 retainer worsen hypercapnia.
When is intubation needed instead of NIV?
When the patient cannot protect their airway, is haemodynamically unstable, or is not improving on a proper trial of non-invasive ventilation.
Related free cases
No account. No card.
Try twenty of these, unmarked.
A worked case shows the reasoning. A session shows you where you stand.
No account. No card.